IPS Research Company

Summary

IPS Research Company is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Attention-Deficit/Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder (ADHD), Major Depressive Disorder, Depression, Migraine and other specialties. IPS Research Company is involved with conducting 150 clinical trials across 91 conditions. There are 1 research doctors associated with this hospital, such as Louise M. Thurman.

Top PIs

Clinical Trials running at IPS Research Company

Migraine

Vestibular Migraine

Depression

Irritable Bowel Syndrome

Hyperacusis

Photophobia

Nausea and Vomiting

Bipolar Disorder

Adolescent Health

Pediatric Migraine

Lasmiditan

for Pediatric Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

Recruiting

2 awards

Phase 3

Rimegepant

for Pediatric Migraine

This trial aims to test the safety of rimegepant, a medication for treating migraines. The study focuses on children and adolescents aged 6 to 17 years who experience moderate to severe migraines. Rimegepant works by blocking a protein that triggers migraine pain, helping to alleviate symptoms.

Recruiting

2 awards

Phase 3

8 criteria

Ubrogepant

for Pediatric Migraine

This trial will test if ubrogepant is safe and effective for young people with migraines. Ubrogepant is a medication taken by mouth to treat migraine headaches. It works by blocking a protein in the brain that causes migraine pain. The study focuses on children and adolescents who suffer from migraines.

Recruiting

1 award

Phase 3

4 criteria